Huihong Xu, MD
Department of Pathology
Boston University School of Medicine
Department of Pathology and Laboratory Medicine
Boston, MA 02118, USA
Dr. Xu received her Medical Degree from Medical Center of Fudan University, Shanghai, China. She completed her pathology residency at Boston University and Boston Medical Center and served as chief resident in 2005 and 2006. She earned a Fellowship in Cytopathology in the same department and post-fellowship joined the Faculty of the Department of Pathology and Laboratory Medicine. She holds additional sub-specialty expertise in GI pathology, genitourinary pathology, head and neck pathology, thyroid pathology and breast pathology. She has served as an Assistant Professor and Staff Pathologist in the Department since 2008. She has also served as the chief of Pathology at a local community hospital Lemuel Shattuck Hospital since 2012. Dr. Xu is board certified in anatomic pathology, clinical pathology and cytopathology.
She is also a great teacher for medical school students, dental school students, residents and fellows in training. She has been invited to be the speaker of multiple local and international meetings and lectures.
Her research interests include: Translational research, especially in colon, esophageal, head and neck, thyroid and prostate cancer.
• (2005) VERNON S.TRUELL Award for excellence on the autopsy service, Mallory
Institute of Pathology, Boston University Medical Center, Boston, MA
• (1991) Excellent Student of the Year, Medical Center of Fudan University, Shanghai, China
• (1988) Excellent Student of the Year, Medical Center of Fudan University, Shanghai, China
• (2004-Present) College of American Pathologists (CAP)
• (2004-Present) United States and Canadian Academy of Pathology (USCAP)
• (2004-2009) American Society for Clinical Pathology (ASCP)
• (2006-2008) American Medical Association (AMA)
• (2007-Present) Chinese American Pathologists Association (CAPA)
• (2008-2009) Massachusetts Medical Society (MMS)
ORIGINAL, PEER REVIEWED ARTICLES
1. Fujita A, Xu H, Chang Y, Jalisi S, Sakai O. Best cases from the AIRP: Malignant mixed tumor of the hard plate. Radio Graphics. 2015; 35: 1186-1190.
2. The I, Ruijtenberg S, Bouchet B, et al. Rb and the APC/C co-activator FZR1 determine CDK4/6-Cyclin D requirement in C. elegans and human cancer cells. Nature Communications. 2015; 6: 5906. doi: 10.1038/ncomms6906
3. Lee NG, Alexander MP, Xu H, Wang DS. Renal Inflammatory Myofibroblastic Tumor: A Case Report and Comprehensive Review of Literature. World Journal of Oncology. 2011. doi: 10.4021/wjon287w
4. Lerner A, Xu H, Antman KH. Sarcoma of soft tissue and bone. ACP Medicine. 2011; 12: 8.
5. OBrien MJ, Yang S, Bucknor Y, et al. Comparison of microsatellite instability, CPG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006; 30(12): 1491-1501.
6. Srinivasan D, Fisk R, Xu H, van den Heuvel S. A complex of LIN-5 and GPR proteins regulates G protein signaling and spindle function in C. elegans. Genes & Development. 2003; 17: 1225-1239.
7. White R, Xu H, Münch T, Bennet R, Grable E. The retina of Manduca sexta: rhodopsin expression, the mosaic of green-, blue- and UV-sensitive photoreceptors, and regional specialization. JEB. 2003; 206: 3337-3348. doi: 10.1242/jeb.00571